Nuvectis Pharma, Inc.
Industry
- Pharmaceuticals
- Vaccines
- Biotechnology
Latest on Nuvectis Pharma, Inc.
"Tulip mania" was the first documented major economic bubble and also one of the most famous market crashes. It happened during the seventeenth century in Holland when speculators sent prices of tulip
At first glance, the 14 biopharmaceutical firms that went public during the first half of 2022 appear to be holding up well with an average return of 25% versus their initial public offering values. H
Initial public offerings in the US are in a slump, with just nine biopharmaceutical company IPOs during the first quarter, raising a total of $807m. The Q1 tally is a fraction of the offerings and the
The biopharmaceutical industry is nearing the one-month mark without an initial public offering in the US as biotechnology stock values continue to plummet, mirroring the slowdown across industries as